These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16255220)

  • 21. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of octagam and pentaglobin in the treatment of severe sepsis in the neonatal period].
    Barinov AV; Ol'mezov VV
    Anesteziol Reanimatol; 1999; (3):59-60. PubMed ID: 10458040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of neonatal sepsis.
    Baird JS; Johnson J
    J Pediatr; 1992 Sep; 121(3):497-8. PubMed ID: 1517935
    [No Abstract]   [Full Text] [Related]  

  • 25. Hark back: passive immunotherapy for influenza and other serious infections.
    Luke TC; Casadevall A; Watowich SJ; Hoffman SL; Beigel JH; Burgess TH
    Crit Care Med; 2010 Apr; 38(4 Suppl):e66-73. PubMed ID: 20154602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin for neonates.
    Green A
    MCN Am J Matern Child Nurs; 1991; 16(4):208-11. PubMed ID: 1943529
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous immunoglobulin: what nurses need to know.
    Meaux JB
    J Perinat Neonatal Nurs; 1996 Mar; 9(4):63-9. PubMed ID: 8699368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice and perception--a nationwide survey of therapy habits in sepsis.
    Brunkhorst FM; Engel C; Ragaller M; Welte T; Rossaint R; Gerlach H; Mayer K; John S; Stuber F; Weiler N; Oppert M; Moerer O; Bogatsch H; Reinhart K; Loeffler M; Hartog C;
    Crit Care Med; 2008 Oct; 36(10):2719-25. PubMed ID: 18766100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
    Conti DJ; Freed BM; Lempert N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of a consensus-assisted protocol--a new approach to improve study design.
    Neugebauer EA
    Eur J Surg Suppl; 1999; (584):7-11. PubMed ID: 10890225
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.
    Hemming VG
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):859-63. PubMed ID: 11527792
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
    Prucha M; Zazula R; Russwurm S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment with immunoglobulins].
    Junker U
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):105-9. PubMed ID: 10355059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a place for hyperimmune globulins in the treatment of refractory infections?
    Boyce N
    Transfus Med Rev; 2001 Apr; 15(2):157-68. PubMed ID: 11309735
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of Predisposition, Insult/Infection, Response, and Organ dysfunction, Acute Physiology And Chronic Health Evaluation II, and Mortality in Emergency Department Sepsis in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle.
    Nguyen HB; Van Ginkel C; Batech M; Banta J; Corbett SW
    J Crit Care; 2012 Aug; 27(4):362-9. PubMed ID: 22033054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: a case report.
    Kyles DM; Baltimore J
    Am J Crit Care; 2005 Mar; 14(2):109-12. PubMed ID: 15728952
    [No Abstract]   [Full Text] [Related]  

  • 37. Considering the demand for and prioritization of intravenous immunoglobulin.
    Orange JS
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):78-82. PubMed ID: 25546771
    [No Abstract]   [Full Text] [Related]  

  • 38. Key process indicators of mortality in the implementation of protocol-driven therapy for severe sepsis.
    Wang JL; Chin CS; Chang MC; Yi CY; Shih SJ; Hsu JY; Wu CL
    J Formos Med Assoc; 2009 Oct; 108(10):778-87. PubMed ID: 19864198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 40. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
    Neugebauer EA
    Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.